Latest News - Galderma

Monday, July 17, 2017 | Business of Medicine, Galderma

Galderma CareConnect Patient Savings Card Program Passes Milestone

The Galderma CareConnect patient savings program has surpassed the mark of 1,000,000 prescriptions filled through its patient access program. Committed to keeping accessibility remarkably simple and s…

Read the full story

Monday, July 17, 2017 | Corporate Lawsuits, PracticalDermatology.com, Galderma

Patent Challenge Filed for Generic Version Of Soolantra Cream

Perrigo Company plc's subsidiary has filed a Paragraph IV Abbreviated New Drug Application with the FDA for a generic version of Soolantra® (ivermectin) cream, 1%. Following notification fr…

Read the full story

Wednesday, July 05, 2017 | PracticalDermatology.com, Research and Publications, Galderma

Study: Soolantra is Both Anti-Inflammatory and Anti-Demodex

A recently published study sought to find scientific rationale for the dual anti-inflammatory and anti-parasitic mode of action of topical ivermectin 1% cream (Soolantra) in patients with rosacea. …

Read the full story

Thursday, April 06, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Galderma

Phase 4 Studies of Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit

Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that…

Read the full story

Thursday, March 02, 2017 | PracticalDermatology.com, Product Launches and Updates, Galderma

Galderma Moves to Differentiate Their Two New HA Fillers From The Fray

With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --Restylane Refyne and Restylane Defyne  --stand o…

Read the full story

Thursday, March 02, 2017 | Personnel/Company News, PracticalDermatology.com, Galderma, Modernizing Medicine

Modernizing Medicine and Galderma Team Up to Offer Integrated OTC eCommerce Platform

Specialty-specific health information technology company Modernizing Medicine, Inc. and Galderma Laboratories, L.P. are collaborating to deliver new capabilities in support of improved patient experie…

Read the full story

Thursday, March 02, 2017 | Business of Medicine, Healthcare Trends, Personnel/Company News, PracticalDermatology.com, Galderma

Galderma and Colorescience Launch Collaboration

Galderma will collaborate with Colorescience to expand skincare solutions to individuals who seek innovative daily skincare products that can be used in conjunction with traditional facial injectable …

Read the full story

Thursday, February 02, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Galderma

Galderma’s OTC Differin Gel Hits Store Shelves

Galderma’s Differin Gel 0.1% (adapalene) is now available over the counter (OTC) at major retail and drug stores. Galderma officially launched the gel at a New York City media fete, and …

Read the full story

Monday, December 12, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Galderma

Galderma's Restylane Refyne and Restylane Defyne Fillers FDA Approved for “Laugh Lines”

The FDA  approved two new products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21 -- Galderma's Restylane Refyne and Restylane Defyne…

Read the full story

Monday, August 29, 2016 | Personnel/Company News, PracticalDermatology.com, Galderma

Cetaphil® Marks Fifth Year of Support for CSDF and Camp Wonder

Galderma Laboratories, L.P., makers of Cetaphil, is celebrating the fifth consecutive year of its "Meaningphil™" partnership with the Children's Skin Disease Foundation (…

Read the full story

Thursday, July 21, 2016 | Personnel/Company News, PracticalDermatology.com, Galderma

Galderma and Chugai Announce Global License Agreement for Nemolizumab, Novel Biologic for Skin Diseases

Chugai Pharmaceutical Co., Ltd. and Galderma Pharma S.A. have entered into a global license agreement for nemolizumab (CIM331), the anti-IL-31 receptor A humanized monoclonal antibody created by Chuga…

Read the full story

Friday, July 08, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Galderma

FDA Greenlights First-Ever OTC Retinoid

The U.S. Food and Drug Administration (FDA) approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne in people 12 years of age and older. …

Read the full story

Tuesday, June 28, 2016 | PracticalDermatology.com, Research and Publications, Allergan , Galderma, Merz

It’s Official: Botox Makes Us Feel Better About Ourselves

Patient satisfaction with overall facial appearance increases by 28 percent with botulinum toxin type A injections to the glabellar rhytids, according to new research in the Aesthetic Surgery Journal.…

Read the full story

Thursday, June 16, 2016 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Galderma

Galderma's Cetaphil® Launches Limited-edition Product Display Honoring Camp Wonder

Galderma Laboratories is unveiling a limited-edition product display in partnership with the Children's Skin Disease Foundation (CSDF) and Camp Wonder, an initiative of the CSDF.  As part …

Read the full story

Friday, June 10, 2016 | Personnel/Company News, PracticalDermatology.com, Product Launches and Updates, Galderma

Restylane Turns 20, Galderma Launches New Syringe

Happy 20th Restylane®! Galderma is celebrating the 20th anniversary of the Restylane line of products. The line includes Restylane®, Restylane-L®, Restylane® Lyft with Lidocaine and…

Read the full story
Load More